Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Metformin Use on Treatment Outcome in NSCLC Patients

NCT02109549 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.

NCT NCT02109549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02109549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Metformin Use on Treatment Outcome in NSCLC Patients
Lead sponsor
Maastricht Radiation Oncology
Phase
Observational
Overall status
Completed
Start date
March 31, 2014
Completion date
February 29, 2016
Enrollment
70 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer